Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders

Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disorders

US Patent 11180760 · Granted Nov 23, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for the expression of CRISPR guide RNAs using the H1 pr2024
Compositions and methods comprising improvements of CRISPR guide RNAS using the 2023
Compositions and methods comprising improvements of CRISPR guide RNAS using the 2023
Sunitinib formulations and methods for use thereof in treatment of glaucoma2021
Sunitinib formulations and methods for use thereof in treatment of glaucoma2021
Compositions and methods for the expression of CRISPR guide RNAS using the H1 pr2020
Sunitinib formulations and methods for use thereof in treatment of glaucoma2020
Sunitinib formulations and methods for use thereof in treatment of glaucoma2020
Compositions and methods for the expression of CRISPR guide RNAs using the H1 pr2019
Compositions and methods for the expression of CRISPR guide RNAs using the H1 pr2019
Compositions and methods for the expression of CRISPR guide RNAs using the H1 pr2018
Methods of identifying neuroprotective compounds for retinal ganglion cells2017